# Safety, PK and PD Study in Healthy Male Japanese Subjects

> **NCT00447941** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 24 (—)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** SCA-136

## Key facts

- **NCT ID:** NCT00447941
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 24 (—)
- **Last updated:** 2009-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00447941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00447941, "Safety, PK and PD Study in Healthy Male Japanese Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00447941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*